Potential of low apolipoprotein A-I as a surrogate marker of vulnerable carotid artery plaques

Saya Tsuchigauchi1, Toshinori Matsushige2, Yukishige Hashimoto3

  • 1Department of Neurology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, Japan.

Insights

Low apolipoprotein A-I (apoA-I) levels are linked to symptomatic carotid artery stenosis. This finding suggests apoA-I may serve as a marker for detecting unstable carotid plaques, improving stroke risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Biochemistry

Background:

  • Medical control of atherogenic lipoproteins is insufficient for stroke prevention.
  • Low apolipoprotein A-I (apoA-I) levels may impact high-density lipoprotein (HDL-C) anti-atherogenic effects.
  • ApoA-I is potentially associated with vulnerable plaques in carotid artery stenosis.

Purpose of the Study:

  • Investigate the relationship between apolipoprotein A-I (apoA-I) levels and carotid artery stenosis status.
  • Identify predictors of symptomatic carotid artery stenosis.
  • Evaluate apoA-I as a potential marker for plaque instability.

Main Methods:

  • Examined 91 patients with carotid artery stenosis, categorized into symptomatic (n=47) and asymptomatic (n=44).
  • Assessed patient profiles, comorbidities, lipid data, and plaque features using ultrasonography, MRI, and digital subtraction angiography.
  • Utilized multivariate logistic regression to identify risk factors for symptomatic stenosis.

Main Results:

  • Symptomatic plaques showed ulceration, low echo luminance, and high T1 signal intensity.
  • Symptomatic patients had significantly lower levels of apoA-I, total cholesterol, and non-HDL-C.
  • Low apoA-I, ulceration, and low echo luminance predicted symptomatic stenosis (diagnostic accuracy 0.84 when combined with high T1 signal intensity).

Conclusions:

  • Low apolipoprotein A-I (apoA-I) levels are significantly associated with symptomatic carotid artery stenosis.
  • ApoA-I levels show potential as a surrogate marker for identifying unstable carotid plaques.
  • This highlights the importance of apoA-I in assessing stroke risk in patients with carotid artery disease.
Abstract